Bellmunt, J., Gupta, S., Duran, M. A. C., Kose, F., Trindade, K. M. D., Marinelarena, N. S., Tambaro, R., Huddart, R. A., Gajate, P., Birtle, A. J., Guo, H., Fukawa, T., Komaru, A., Kageyama, Y., Obara, W., Ci, B., Steinberg, E., Soong, J., Connor-Ahmad, S., Powles, T. (2026). Patient-reported outcomes from IMvigor011: A phase 3 study of circulating tumor (ct)DNA–guided adjuvant atezolizumab vs placebo in muscle-invasive bladder cancer (MIBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4627